Skip to main content

Distrust, Fear Hamper COVID Vaccinations, Clinical Trial Diversity

By October 18, 2021News
Coronavirus covid 19 vaccine covid19 vaccination 2021 09 02 03 08 04 utc

Coronavirus covid 19 vaccine covid19 vaccination 2021 09 02 03 08 04 utc

TYSONS CORNER, Va., Oct. 12, 2021 /PRNewswire-PRWeb/ — As of late September, 77% of the total adult population of the U.S. had received at least one dose of a COVID-19 vaccine. Black and Hispanic people, however, remain less likely than whites to have received a vaccine, leaving them at increased risk of infection, particularly as the novel variant spreads.(1) Some of this hesitance to vaccination, notes Dr. Harsha Rajasimha, founder and CEO of Jeeva Informatics, is rooted in long-lost trust. “We see it in clinical trials as well,” he says. “Black and brown people need the medicines and therapies being developed but are less inclined to trust the professionals who develop them.” This is unfortunate.

 

{iframe}https://finance.yahoo.com/news/distrust-fear-hamper-covid-vaccinations-160500704.html{/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.